Nama Insights

iShares Biotechnology ETF (IBB)

Health · iShares · NASDAQ

HealthETF
iShares Biotechnology ETF (IBB) is an exchange-traded fund in the Health category. It has $9.09B in assets, an expense ratio of 0.44% and a 0.22% dividend yield. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Assets under management$9.09B
Expense ratio0.44%
CategoryHealth
Dividend yield0.22%
NAV$186.02
Fund familyiShares
ExchangeNASDAQ

Top holdings

The largest positions iShares Biotechnology ETF reports, by weight.

HoldingNameWeight
VRTX Vertex Pharmaceuticals Inc 8.07%
AMGN Amgen Inc 7.82%
GILD Gilead Sciences Inc 6.83%
REGN Regeneron Pharmaceuticals Inc 4.90%
ARGX argenx SE ADR 3.75%
ALNY Alnylam Pharmaceuticals Inc 3.12%
NTRA Natera Inc 2.89%
RVMD Revolution Medicines Inc Ordinary Shares 2.78%
BIIB Biogen Inc 2.46%
ILMN Illumina Inc 2.07%

Other Health ETFs

Explore live IBB data on Nama Insights →